vs
华利安（HLI）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是华利安的2.0倍（$1.4B vs $717.1M），瑞思迈净利率更高（27.6% vs 16.3%，领先11.3%），华利安同比增速更快（13.0% vs 11.0%），过去两年华利安的营收复合增速更高（17.4% vs 7.8%）
华利安是美国知名跨国独立投资银行及金融服务机构，1972年成立，总部位于加利福尼亚州洛杉矶世纪城的星座广场。公司为上市企业、非公众公司、机构及政府主体提供专业服务，核心业务涵盖并购咨询、资本解决方案、重组与困境并购、公允意见出具，以及财务与估值顾问等领域。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
HLI vs RMD — 直观对比
营收规模更大
RMD
是对方的2.0倍
$717.1M
营收增速更快
HLI
高出2.1%
11.0%
净利率更高
RMD
高出11.3%
16.3%
两年增速更快
HLI
近两年复合增速
7.8%
损益表 — Q3 FY2026 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $717.1M | $1.4B |
| 净利润 | $116.5M | $392.6M |
| 毛利率 | 32.2% | 61.8% |
| 营业利润率 | 22.4% | 34.6% |
| 净利率 | 16.3% | 27.6% |
| 营收同比 | 13.0% | 11.0% |
| 净利润同比 | 22.3% | 13.9% |
| 每股收益（稀释后） | $1.70 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HLIRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.4B | ||
| Q4 25 | $717.1M | $1.4B | ||
| Q3 25 | $659.5M | $1.3B | ||
| Q2 25 | $605.3M | $1.3B | ||
| Q1 25 | $666.4M | $1.3B | ||
| Q4 24 | $634.4M | $1.3B | ||
| Q3 24 | $575.0M | $1.2B |
净利润HLIRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | — | $398.7M | ||
| Q4 25 | $116.5M | $392.6M | ||
| Q3 25 | $111.8M | $348.5M | ||
| Q2 25 | $97.5M | $379.7M | ||
| Q1 25 | $121.9M | $365.0M | ||
| Q4 24 | $95.3M | $344.6M | ||
| Q3 24 | $93.5M | $311.4M |
毛利率HLIRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | 32.2% | 61.8% | ||
| Q3 25 | 33.8% | 61.5% | ||
| Q2 25 | 31.0% | 60.8% | ||
| Q1 25 | 33.9% | 59.3% | ||
| Q4 24 | 31.4% | 58.6% | ||
| Q3 24 | 33.0% | 58.6% |
营业利润率HLIRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | 22.4% | 34.6% | ||
| Q3 25 | 22.9% | 33.4% | ||
| Q2 25 | 14.8% | 33.7% | ||
| Q1 25 | 20.9% | 33.0% | ||
| Q4 24 | 21.5% | 32.5% | ||
| Q3 24 | 22.7% | 31.6% |
净利率HLIRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | — | 27.9% | ||
| Q4 25 | 16.3% | 27.6% | ||
| Q3 25 | 17.0% | 26.1% | ||
| Q2 25 | 16.1% | 28.2% | ||
| Q1 25 | 18.3% | 28.3% | ||
| Q4 24 | 15.0% | 26.9% | ||
| Q3 24 | 16.3% | 25.4% |
每股收益（稀释后）HLIRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | — | $2.74 | ||
| Q4 25 | $1.70 | $2.68 | ||
| Q3 25 | $1.63 | $2.37 | ||
| Q2 25 | $1.42 | $2.58 | ||
| Q1 25 | $1.76 | $2.48 | ||
| Q4 24 | $1.39 | $2.34 | ||
| Q3 24 | $1.37 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $1.4B |
| 总债务越低越好 | — | $663.8M |
| 股东权益账面价值 | $2.3B | $6.3B |
| 总资产 | $3.9B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资HLIRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $923.6M | $1.4B | ||
| Q2 25 | $793.8M | $1.2B | ||
| Q1 25 | $971.0M | $932.7M | ||
| Q4 24 | $799.3M | $521.9M | ||
| Q3 24 | $691.4M | $426.4M |
总债务HLIRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
股东权益HLIRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | $6.5B | ||
| Q4 25 | $2.3B | $6.3B | ||
| Q3 25 | $2.2B | $6.1B | ||
| Q2 25 | $2.2B | $6.0B | ||
| Q1 25 | $2.2B | $5.5B | ||
| Q4 24 | $2.1B | $5.3B | ||
| Q3 24 | $2.0B | $5.2B |
总资产HLIRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | — | $8.8B | ||
| Q4 25 | $3.9B | $8.5B | ||
| Q3 25 | $3.8B | $8.3B | ||
| Q2 25 | $3.5B | $8.2B | ||
| Q1 25 | $3.8B | $7.6B | ||
| Q4 24 | $3.5B | $7.1B | ||
| Q3 24 | $3.2B | $7.2B |
负债/权益比HLIRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $217.7M | — |
| 自由现金流经营现金流 - 资本支出 | $217.0M | — |
| 自由现金流率自由现金流/营收 | 30.3% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | 1.87× | — |
| 过去12个月自由现金流最近4个季度 | $738.9M | — |
8季度趋势，按日历期对齐
经营现金流HLIRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $217.7M | $339.7M | ||
| Q3 25 | $325.0M | $457.3M | ||
| Q2 25 | $-131.6M | $538.8M | ||
| Q1 25 | $358.4M | $578.7M | ||
| Q4 24 | $265.5M | $308.6M | ||
| Q3 24 | $289.2M | $325.5M |
自由现金流HLIRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $217.0M | $311.2M | ||
| Q3 25 | $322.8M | $414.4M | ||
| Q2 25 | $-144.8M | $508.2M | ||
| Q1 25 | $343.9M | $557.9M | ||
| Q4 24 | $261.7M | $288.0M | ||
| Q3 24 | $278.7M | $307.7M |
自由现金流率HLIRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 30.3% | 21.9% | ||
| Q3 25 | 49.0% | 31.0% | ||
| Q2 25 | -23.9% | 37.7% | ||
| Q1 25 | 51.6% | 43.2% | ||
| Q4 24 | 41.2% | 22.5% | ||
| Q3 24 | 48.5% | 25.1% |
资本支出强度HLIRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 2.0% | ||
| Q3 25 | 0.3% | 3.2% | ||
| Q2 25 | 2.2% | 2.3% | ||
| Q1 25 | 2.2% | 1.6% | ||
| Q4 24 | 0.6% | 1.6% | ||
| Q3 24 | 1.8% | 1.5% |
现金转化率HLIRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.87× | 0.87× | ||
| Q3 25 | 2.91× | 1.31× | ||
| Q2 25 | -1.35× | 1.42× | ||
| Q1 25 | 2.94× | 1.59× | ||
| Q4 24 | 2.79× | 0.90× | ||
| Q3 24 | 3.09× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HLI
| Corporate Finance | $473.7M | 66% |
| Financial Restructuring | $156.3M | 22% |
| Financial Advisory Services | $87.1M | 12% |
RMD
暂无分部数据
